NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/14/2023
Back to search
Official data from USPTO
THYROID SPECIFIC FORMULATIONS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
02/14/2023
Trademark type
Combined
Nice classes
5
Filing date
06/21/2021
Registration date
02/14/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/14/2023
Last transaction
02/14/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
06/17/2021
First use in commerce
06/17/2021
Drawing code
3
Owner type
16
Owner location
Scottsdale, AZ, US
Examiner
TARABAN, LAURA
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Thyroid Specific Formulations LLC
Representatives
Daniel R. Pote JENNINGS, STROUSS & SALMON, P.L.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Nutritional supplements; Dietary supplements
Publications
History of USPTO decisions and trademark events.
26 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/14/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/29/2022
PUBO
PUBLISHED FOR OPPOSITION
11/29/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/09/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/24/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
10/24/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/24/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
10/24/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/24/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/13/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/12/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/12/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/12/2022
GNRT
NON-FINAL ACTION E-MAILED
09/12/2022
CNRT
NON-FINAL ACTION WRITTEN
09/12/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/08/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/08/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/16/2022
GNRT
NON-FINAL ACTION E-MAILED
03/16/2022
CNRT
NON-FINAL ACTION WRITTEN
03/16/2022
DOCK
ASSIGNED TO EXAMINER
03/11/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/07/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/05/2021
NWAP
NEW APPLICATION ENTERED
06/24/2021
Continuous trademark protection
Get notified about every new filing that threatens THYROID SPECIFIC FORMULATIONS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.